Odds ratio | p-value | 95% confidence interval | ||
---|---|---|---|---|
pCR (simple regression) | ||||
Age group (≤ 50 vs. > 50) | 1.09 | 0.79 | 0.57 | 2.08 |
cT1, 2 vs. cT3, 4 | 0.40 | 0.017 | 0.18 | 0.85 |
N0 vs. N+ | 0.48 | 0.116 | 0.20 | 1.20 |
HR (positive) | 0.74 | 0.378 | 0.38 | 1.44 |
HER2 (positive) | 1.21 | 0.624 | 0.57 | 2.58 |
Optimal chemotherapy (yes) | 3.05 | 0.018 | 1.22 | 7.64 |
KI-67 (high) | 2.25 | 0.056 | 0.98 | 5.19 |
pCR (multiple regression) | ||||
Age group (≤ 50 vs. > 50)* | 1.09 | 0.854 | 0.43 | 2.77 |
cT1, 2 vs. cT3, 4* | 0.28 | 0.008 | 0.11 | 0.71 |
N0 vs. N+* | 0.59 | 0.4 | 0.17 | 2.01 |
HR (positive)* | 0.69 | 0.435 | 0.27 | 1.78 |
Optimal chemotherapy (yes)* | 1.49 | 0.016 | 1.08 | 2.06 |